MUFA-SIRT1 signaling as a central node regulating healthspan

MUFA-SIRT1 信号传导作为调节健康寿命的中心节点

基本信息

  • 批准号:
    10711019
  • 负责人:
  • 金额:
    $ 31.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-15 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

Diet is a major regulator of most if not all aging-related diseases. The Mediterranean Diet is widely regarded as the gold standard of diets due to its ability to reduce a wide range of aging-related diseases resulting in improved healthspan. While numerous components of the Mediterranean Diet likely contribute to its health benefits, extra virgin olive oil has emerged as a major constituent underlying these effects. Indeed, both epidemiological and interventional studies have linked extra virgin olive oil consumption to improved health benefits including reductions in cognitive decline and neurodegenerative diseases. Extra virgin olive oil is largely comprised of oil enriched in monounsaturated fatty acids (MUFA) as well as a diverse class of phenolic compounds. Interestingly, both MUFAs and the many phenols found in extra virgin olive oil have been shown in pre-clinical and clinical trials to have positive effects on cognition and in the prevention of Alzheimer’s Disease and related dementias. Our laboratory has found the MUFAs are allosteric activators of sirtuin 1 (SIRT1), a key nutrient sensing protein that regulates a plethora of pathways controlling aging-related pathologies. Numerous phenols, including some found in extra virgin olive oil, also can activate SIRT1 to improve aging related outcomes and, as we have shown, these small molecules likely activate SIRT1 through the same mechanism as MUFAs. Thus, deciphering the health benefits of MUFAs vs non-lipid components in olive oil, and the extent to which SIRT1 allosteric activation mediates these effects, would greatly advance our understanding of the Mediterranean Diet, the health benefits of olive oil, and SIRT1 biology. In addition, MUFA signaling to SIRT1 occurs upon conditions that stimulate lipolysis such as fasting or caloric restriction suggesting that diet composition and eating patterns are co-dependent. Based upon these data, we hypothesize that MUFAs and extra virgin olive oil phenols will prevent declines in cognition and neurological impairments via SIRT1 activation and will modulate the effects of caloric restriction. To test our hypothesis, we will conduct the following two aims. 1) To test the effects of extra virgin olive oil MUFAs and phenols signaling via SIRT1 on aging-related neurodegeneration. In this aim, we will feed wild-type or SIRT1 E222K mice, which lack responsiveness to SIRT1 allosteric activators, diets enriched in olive oil with high or low phenolic content and comprehensively characterize neurological function and cognition. 2) To determine impact of olive oil and caloric restriction alone or in combination on neurodegeneration. We will feed middle- aged mice diets with low or high MUFA along under ad libitum or caloric restriction conditions to determine if the interaction between these two dietary interventions impacts cognition and neural function. We expect these studies to advance our understanding into how dietary lipids and caloric restriction impact the aging brain, which will help define new mechanisms underlying neurodegenerative diseases and open new therapeutic avenues targeting lipid metabolism.
饮食是大多数(如果不是全部的话)与衰老有关的疾病的主要调节因素。地中海饮食被广泛推崇

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Douglas G Mashek其他文献

Douglas G Mashek的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Douglas G Mashek', 18)}}的其他基金

Lipid droplets and the compartmentalization of subcellular metabolism
脂滴和亚细胞代谢的区室化
  • 批准号:
    10589330
  • 财政年份:
    2023
  • 资助金额:
    $ 31.76万
  • 项目类别:
MUFA-SIRT1 signaling as a central node regulating healthspan
MUFA-SIRT1信号作为调节健康寿命的中心节点
  • 批准号:
    10646427
  • 财政年份:
    2020
  • 资助金额:
    $ 31.76万
  • 项目类别:
MUFA-SIRT1 signaling as a central node regulating healthspan
MUFA-SIRT1信号作为调节健康寿命的中心节点
  • 批准号:
    10432079
  • 财政年份:
    2020
  • 资助金额:
    $ 31.76万
  • 项目类别:
MUFA-SIRT1 signaling as a central node regulating healthspan
MUFA-SIRT1信号作为调节健康寿命的中心节点
  • 批准号:
    10263268
  • 财政年份:
    2020
  • 资助金额:
    $ 31.76万
  • 项目类别:
MUFA-SIRT1 signaling as a central node regulating healthspan
MUFA-SIRT1信号作为调节健康寿命的中心节点
  • 批准号:
    10092409
  • 财政年份:
    2020
  • 资助金额:
    $ 31.76万
  • 项目类别:
Regulation and consequences of hepatic lipid droplet catabolism
肝脏脂滴分解代谢的调节和后果
  • 批准号:
    9926393
  • 财政年份:
    2017
  • 资助金额:
    $ 31.76万
  • 项目类别:
Role of ATGL and lipid metabolism in healthspan
ATGL 和脂质代谢在健康寿命中的作用
  • 批准号:
    9902277
  • 财政年份:
    2017
  • 资助金额:
    $ 31.76万
  • 项目类别:
Role of ATGL and lipid metabolism in healthspan
ATGL 和脂质代谢在健康寿命中的作用
  • 批准号:
    9285055
  • 财政年份:
    2017
  • 资助金额:
    $ 31.76万
  • 项目类别:
Regulation and consequences of hepatic lipid droplet catabolism
肝脏脂滴分解代谢的调节和后果
  • 批准号:
    9366252
  • 财政年份:
    2017
  • 资助金额:
    $ 31.76万
  • 项目类别:
Role of ATGL and lipid metabolism in healthspan
ATGL 和脂质代谢在健康寿命中的作用
  • 批准号:
    9344823
  • 财政年份:
    2016
  • 资助金额:
    $ 31.76万
  • 项目类别:

相似海外基金

Novel mechanisms for Alzheimer disease prevention and or treatment
预防和/或治疗阿尔茨海默病的新机制
  • 批准号:
    10155429
  • 财政年份:
    2019
  • 资助金额:
    $ 31.76万
  • 项目类别:
Novel mechanisms for Alzheimer disease prevention and or treatment
预防和/或治疗阿尔茨海默病的新机制
  • 批准号:
    9906046
  • 财政年份:
    2019
  • 资助金额:
    $ 31.76万
  • 项目类别:
Novel mechanisms for Alzheimer disease prevention and or treatment
预防和/或治疗阿尔茨海默病的新机制
  • 批准号:
    10455418
  • 财政年份:
    2019
  • 资助金额:
    $ 31.76万
  • 项目类别:
Pathology of the Alzheimer disease : prevention of cerebral β-amyloid deposition
阿尔茨海默病的病理学:预防大脑β-淀粉样蛋白沉积
  • 批准号:
    19300122
  • 财政年份:
    2007
  • 资助金额:
    $ 31.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了